Dr. Kartik Konduri, MD
Claim this profileTexas Oncology-Baylor Charles A. Sammons Cancer Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
12 reported clinical trials
23 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
NRG1 positive
2Non-Small Cell Lung Cancer
Stage IV
Stage III
Progression
Affiliated Hospitals
Clinical Trials Kartik Konduri, MD is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
Quaratusugene Ozeplasmid + Atezolizumab
for Small Cell Lung Cancer
This clinical trial will evaluate the combination of quaratusugene ozeplasmid with atezolizumab as maintenance therapy for patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC). The study is comprised of 2 phases, a dose selection phase (Phase 1) and a safety and efficacy evaluation phase (Phase 2).
Recruiting1 award Phase 1 & 210 criteria
More about Kartik Konduri, MD
Clinical Trial Related4 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Kartik Konduri, MD has experience with
- Pemetrexed
- Carboplatin
- Placebo
- Pembrolizumab
- NovoTTF-200T
- Seribantumab
Breakdown of trials Kartik Konduri, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Colorectal Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kartik Konduri, MD specialize in?
Kartik Konduri, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Kartik Konduri, MD currently recruiting for clinical trials?
Yes, Kartik Konduri, MD is currently recruiting for 3 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Kartik Konduri, MD has studied deeply?
Yes, Kartik Konduri, MD has studied treatments such as Pemetrexed, Carboplatin, Placebo.
What is the best way to schedule an appointment with Kartik Konduri, MD?
Apply for one of the trials that Kartik Konduri, MD is conducting.
What is the office address of Kartik Konduri, MD?
The office of Kartik Konduri, MD is located at: Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas 75246 United States. This is the address for their practice at the Texas Oncology-Baylor Charles A. Sammons Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.